The Supreme Court has been navigating a complex legal landscape concerning access to the abortion pill mifepristone, recently allowing both telehealth consultations and mail orders to continue temporarily. Despite significant challenges, including appeals from states like Louisiana urging stricter regulations, the Court has upheld broad access for now, ensuring that mifepristone remains available nationwide. However, dissenting opinions from Justices Alito and Thomas highlight ongoing divisions. With legal battles ongoing, providers are striving to adapt and maintain services amid uncertainty.